Sage Therapeutics (SAGE) PT Raised to $105 at Stifel
Tweet Send to a Friend
Stifel raised its price target on Sage Therapeutics (NASDAQ: SAGE) to $105.00 (from $91.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
